510(k) K243284

RELiZORB (100300/ 100301) by Alcresta Therapeutics, Inc. — Product Code PLQ

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 15, 2025
Date Received
October 17, 2024
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Packed Cartridge
Device Class
Class II
Regulation Number
876.5985
Review Panel
GU
Submission Type

Hydrolyze fats in enteral formula.